» Articles » PMID: 38201651

Transforming Growth Factor-β/Smad Signaling Inhibits Melanoma Cancer Stem Cell Self-Renewal, Tumor Formation and Metastasis

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Jan 11
PMID 38201651
Authors
Affiliations
Soon will be listed here.
Abstract

The secreted protein transforming growth factor-beta (TGFβ) plays essential roles, ranging from cell growth regulation and cell differentiation in both normal and cancer cells. In melanoma, TGFβ acts as a potent tumor suppressor in melanoma by blocking cell cycle progression and inducing apoptosis. In the present study, we found TGFβ to regulate cancer stemness in melanoma through the Smad signaling pathway. We discovered that TGFβ/Smad signaling inhibits melanosphere formation in multiple melanoma cell lines and reduces expression of the CD133+ cancer stem cell subpopulation in a Smad3-dependent manner. Using preclinical models of melanoma, we further showed that preventing Smad3/4 signaling, by means of CRISPR knockouts, promoted both tumorigenesis and lung metastasis in vivo. Collectively, our results define new functions for the TGFβ/Smad signaling axis in melanoma stem-cell maintenance and open avenues for new therapeutic approaches to this disease.

Citing Articles

Menin in Cancer.

Majer A, Hua X, Katona B Genes (Basel). 2024; 15(9).

PMID: 39336822 PMC: 11431421. DOI: 10.3390/genes15091231.


Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in Melanoma.

Boudreault J, Canaff L, Ghozlan M, Wang N, Guarnieri V, Salcuni A Cells. 2024; 13(11.

PMID: 38891107 PMC: 11172218. DOI: 10.3390/cells13110973.


Cancer Stem Cells from Definition to Detection and Targeted Drugs.

Ruszkowska-Ciastek B, Kwiatkowska K, Marques-da-Silva D, Lagoa R Int J Mol Sci. 2024; 25(7).

PMID: 38612718 PMC: 11011379. DOI: 10.3390/ijms25073903.

References
1.
Lee C, Yu C, Wang B, Chang W . Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs. Oncotarget. 2015; 7(2):1215-26. PMC: 4811455. DOI: 10.18632/oncotarget.6261. View

2.
Samson J, Ravindran Menon D, Smith D, Baird E, Kitano T, Gao D . Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes. Chem Biol Interact. 2019; 314:108822. PMC: 6916670. DOI: 10.1016/j.cbi.2019.108822. View

3.
Dai M, Boudreault J, Wang N, Poulet S, Daliah G, Yan G . Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways. Cancer Res. 2020; 81(5):1332-1346. DOI: 10.1158/0008-5472.CAN-20-2121. View

4.
Lacerte A, Korah J, Roy M, Yang X, Lemay S, Lebrun J . Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal. 2007; 20(1):50-9. DOI: 10.1016/j.cellsig.2007.08.012. View

5.
Montague T, Cruz J, Gagnon J, Church G, Valen E . CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res. 2014; 42(Web Server issue):W401-7. PMC: 4086086. DOI: 10.1093/nar/gku410. View